Patents-Review.com
🔗 Permalink
Assignee profile:

IN3BIO LTD.

City:

Hamilton

Country:

Bermuda

Published Applications:

13

Last publication date:

2026-04-30

Patent Grants:

10

Last grant date:

2026-03-10

Top Inventors for applications by IN3BIO LTD.

These are the the leading inventors for applications assigned to IN3BIO LTD.:

Recent patent applications by IN3BIO LTD.

IN3BIO LTD. based in Hamilton, BM has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-04-30
US20260115267A1
Human necessities

METHODS OF USING ANTI-EGF ANTIBODIES TO AUGMENT THE ACTIVITY OF BRAF AND KRAS INHIBITORS

 #2 | 2025-02-27 ✅ Patent 12,570,708 granted on 2026-03-10
US20250066439A1
Chemistry; metallurgy

RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES

 #3 | 2023-02-09 ✅ Patent 12,433,939 granted on 2025-10-07
US20230042534A1
Human necessities

SELF-ASSEMBLING SYNTHETIC PROTEINS

 #4 | 2022-12-01
US20220378891A1
Human necessities

METHODS AND COMPOSITIONS FOR USE OF GROWTH FACTOR ANTIBODIES IN COMBINATION WITH NON-TYROSINE TARGETING KINASE INHIBITORS

 #5 | 2022-09-29
US20220305105A1
Human necessities

STABILIZED CHIMERIC SYNTHETIC PROTEINS AND THERAPEUTIC USES THEREOF

 #6 | 2022-05-19 ✅ Patent 12,030,920 granted on 2024-07-09
US20220153798A1
Chemistry; metallurgy

Recombinant proteins and their therapeutic uses

 #7 | 2022-02-10 ✅ Patent 12,258,389 granted on 2025-03-25
US20220041704A1
Chemistry; metallurgy

Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitors

 #8 | 2021-01-14 ✅ Patent 12,134,662 granted on 2024-11-05
US20210009716A1
Chemistry; metallurgy

Synthetic proteins and therapeutic uses thereof

 #9 | 2020-09-24 ✅ Patent 11,419,923 granted on 2022-08-23
US20200297827A1
Human necessities

Self-assembling synthetic proteins

 #10 | 2020-02-13 ✅ Patent 12,257,245 granted on 2025-03-25
US20200046690A1
Human necessities

Methods and compositions for inhibition of EGF/EGFR pathway in combination with anaplastic lymphoma kinase inhibitors

 #11 | 2018-06-14 ✅ Patent 11,198,716 granted on 2021-12-14
US20180162917A1
Chemistry; metallurgy

Recombinant proteins and their therapeutic uses

 #12 | 2016-11-17 ✅ Patent 12,595,297 granted on 2026-04-07
US20160333087A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITION OF EGF/EGFR PATHWAY IN COMBINATION WITH TYROSINE KINASE INHIBITORS

 #13 | 2016-04-07 ✅ Patent 10,736,948 granted on 2020-08-11
US20160095910A1
Human necessities

Epidermal growth factor fusion proteins with mutant cholera toxin B subunits

Also check out In3Bio Ltd.'s (Hamilton, Bermuda) applicant profile with 10 patent applications submitted.

AssigneeID:

306320 ⎘